Article Details
Retrieved on: 2019-04-30 04:48:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>Moreover, <b>Benchmark Capital</b> has 0.76% invested in Galectin Therapeutics, Inc. (NASDAQ:GALT). Cutter Brokerage Inc stated it has 57,800 shares.</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here